These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6618773

  • 1. Adverse effect of indomethacin in experimental chronic nephrosis.
    Kleinknecht C, Laouari D, Gubler MC, Gros F.
    Int J Pediatr Nephrol; 1983 Jun; 4(2):83-8. PubMed ID: 6618773
    [Abstract] [Full Text] [Related]

  • 2. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR, Karnovsky MJ.
    J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis.
    Hjalmarsson C, Lidell ME, Haraldsson B.
    Nephrol Dial Transplant; 2006 May; 21(5):1223-30. PubMed ID: 16410268
    [Abstract] [Full Text] [Related]

  • 4. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J, Weening JJ, Elema JD.
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [Abstract] [Full Text] [Related]

  • 5. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y, Shirato I, Maeda A, Kobayashi N, Liao J, Shou I, Fukui M, Tomino Y.
    J Nephrol; 2002 Sep; 15(1):36-41. PubMed ID: 11936424
    [Abstract] [Full Text] [Related]

  • 6. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats.
    Radin MJ, Wilke WL, Fettman MJ.
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):279-82. PubMed ID: 3538253
    [Abstract] [Full Text] [Related]

  • 7. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K, Natori Y, Sato T, Kimura T, Sugiura A, Sato H, Saito T, Ito S, Natori Y.
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [Abstract] [Full Text] [Related]

  • 8. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
    Koide H, Nakamura T, Kimura K, Ebihara I, Nagai R, Tomino Y.
    Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
    Schwartz MM, Sharon Z, Pauli BU, Lewis EJ.
    Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
    [Abstract] [Full Text] [Related]

  • 10. A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss.
    Andrews PM.
    Lab Invest; 1977 Feb; 36(2):183-97. PubMed ID: 839733
    [Abstract] [Full Text] [Related]

  • 11. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
    Lee YK, Kwon T, Kim DJ, Huh W, Kim YG, Oh HY, Kawachi H.
    Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
    Kokui K, Yoshikawa N, Nakamura H, Itoh H.
    J Pathol; 1992 Mar; 166(3):297-301. PubMed ID: 1517884
    [Abstract] [Full Text] [Related]

  • 13. Glomerular mesangium. Analysis of the increased activity observed in experimental acute aminonucleoside nephrosis in the rat.
    Grond J, Elema JD.
    Lab Invest; 1981 Nov; 45(5):400-9. PubMed ID: 7300251
    [Abstract] [Full Text] [Related]

  • 14. [Effects of FK506 on aminonucleoside-induced nephrotic rats].
    Kawaguchi S.
    Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):141-51. PubMed ID: 1375300
    [Abstract] [Full Text] [Related]

  • 15. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS, Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lee HY.
    Yonsei Med J; 2005 Feb 28; 46(1):141-8. PubMed ID: 15744817
    [Abstract] [Full Text] [Related]

  • 16. Activities of lysosomal enzymes in isolated glomeruli. Alterations in experimental nephrosis.
    Velosa JA, Shah SV, Ou SL, Abboud HE, Dousa TP.
    Lab Invest; 1981 Dec 28; 45(6):522-6. PubMed ID: 7321525
    [Abstract] [Full Text] [Related]

  • 17. Differences in puromycin aminonucleoside nephrosis in two rat strains.
    Grond J, Muller EW, van Goor H, Weening JJ, Elema JD.
    Kidney Int; 1988 Feb 28; 33(2):524-9. PubMed ID: 3361753
    [Abstract] [Full Text] [Related]

  • 18. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
    Holthöfer H, Reivinen J, Solin ML, Haltia A, Miettinen A.
    Am J Pathol; 1996 Sep 28; 149(3):1009-15. PubMed ID: 8780404
    [Abstract] [Full Text] [Related]

  • 19. Glomerular podocyte cell junctions in nephrotic syndrome. I. Freeze-fracture studies in rat aminonucleoside nephrosis.
    Kühn K, Sterzel RB, Reale E.
    J Submicrosc Cytol; 1981 Jul 28; 13(3):407-12. PubMed ID: 7334544
    [Abstract] [Full Text] [Related]

  • 20. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
    Ricardo SD, Bertram JF, Ryan GB.
    Exp Nephrol; 1995 Jul 28; 3(5):270-9. PubMed ID: 7583048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.